Thoracic Surgery Clinics is a premier academic journal dedicated to advancing the field of thoracic surgery and related disciplines. Published by W B Saunders Co-Elsevier Inc, this journal has been a vital resource since its inception in 2004, presenting high-quality peer-reviewed articles that embrace the latest research, practice innovations, and clinical guidelines impacting thoracic and respiratory health. With a strong focus on multidisciplinary approaches, it caters to a diverse audience of researchers, medical professionals, and students. The journal currently ranks impressively in the Q2 category within Medicine (miscellaneous), Pulmonary and Respiratory Medicine, and Surgery, indicating its substantial influence and reach in the medical community. While not available as an open access publication, its concentrated aim is to enhance the knowledge base and clinical skills necessary for tackling complex thoracic surgical challenges. Join the ongoing discourse in this dynamic field through Thoracic Surgery Clinics, where cutting-edge research meets practical application.

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

General Thoracic and Cardiovascular Surgery is a pivotal academic journal dedicated to the rapidly evolving fields of thoracic and cardiovascular surgery. Published by SPRINGER JAPAN KK, this journal serves as a vital resource for clinicians, researchers, and medical professionals seeking insights into current practices, innovative techniques, and groundbreaking research. With an ISSN of 1863-6705 and an E-ISSN of 1863-6713, it has established a prominent presence in the academic community, demonstrated by its impressive ranking in the Q3 category for Cardiology and Cardiovascular Medicine and Surgery in 2023. The journal’s standards ensure high-quality, peer-reviewed articles that facilitate knowledge exchange and drive advancements in the field. Although it operates without open access, it remains accessible through library subscriptions and institutional affiliations. Covering a broad span of research from 2007 to 2024, General Thoracic and Cardiovascular Surgery is committed to enlightening its audience with findings that have substantial implications for clinical practices and patient outcomes.

Kardiochirurgia i Torakochirurgia Polska - Polish Journal of Thoracic and Cardiovascular Surgery is an esteemed Open Access journal dedicated to the vibrant fields of thoracic and cardiovascular surgery. Established by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal has been providing a platform for innovative research and clinical practices since its inception. The journal, indexed with ISSN 1731-5530 and E-ISSN 1897-4252, plays a crucial role in disseminating knowledge within its domain, promoting advancements that impact patient care and outcomes. With a history of publication covering from 2008 to 2024, it features high-quality articles with contemporary insights in surgery and cardiology, ranked in Q4 and Q3 categories respectively as of 2023. With its presence in Scopus, where it holds notable ranks in both the surgery and cardiology disciplines, this journal is committed to fostering collaboration and innovation among researchers, professionals, and aspiring students alike, making it an indispensable resource for those engaged in the intricacies of thoracic and cardiovascular surgery.

Thoracic and Cardiovascular Surgeon Reports is a pivotal academic journal dedicated to the dissemination of innovative research and clinical practices in the fields of thoracic and cardiovascular surgery. Published by GEORG THIEME VERLAG KG, this journal has been an open-access publication since 2013, fostering a broader reach and enhancing visibility for authors and researchers globally. With its commitment to high-quality peer-reviewed articles, Thoracic and Cardiovascular Surgeon Reports serves as an essential platform for surgeons, clinicians, and scholars to share findings that advance medical knowledge, improve patient outcomes, and refine surgical techniques. The journal aims to bridge the gap between research and practical application, catering to an audience keen on staying updated with the latest in thoracic and cardiovascular interventions, making it a valuable resource in an ever-evolving medical landscape.

Clinical Lymphoma Myeloma & Leukemia is a prestigious journal dedicated to the study and treatment of hematologic malignancies, offering a vital platform for researchers and healthcare professionals in the fields of oncology, hematology, and cancer research. Published by CIG MEDIA GROUP, LP, this journal has established itself as a crucial resource since its inception in 2010, with a continuous commitment to disseminating knowledge until at least 2024. With an impact factor that objectively reflects its influence, it is rated in Q3 quartiles in both Cancer Research and Hematology as well as in Oncology as of 2023. Researchers can access a wealth of articles and studies that explore various dimensions of lymphoma, myeloma, and leukemia, thus fostering an environment of collaboration and innovation. Although it currently does not offer full open access, its extensive archive and rigorous peer-review process ensure the publication of high-quality research, making it an essential resource for anyone dedicated to advancing the science and practice of treating blood cancers.

The Journal of Gastrointestinal Oncology, published by AME Publishing Company, is a leading open-access journal that focuses on the complex interplay between gastroenterology and oncology. Established in 2012 and converging into a reputable academic platform through 2024, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and management of gastrointestinal cancers. With an ISSN of 2078-6891 and an E-ISSN of 2219-679X, this journal presents articles that are rigorously peer-reviewed, ensuring high-quality content that meets the demands of the scientific community. Despite its current categorization in the Q3 quartile for both Gastroenterology and Oncology as of 2023, it consistently strives to improve its impact and relevance, reflected in its Scopus rankings and percentile metrics. Publishing noteworthy research, reviews, and case studies, the Journal of Gastrointestinal Oncology is instrumental in addressing significant challenges in the field, making it a must-read for those dedicated to advancing knowledge and practice in gastrointestinal oncology.

Interdisciplinary Cardiovascular and Thoracic Surgery, published by Oxford University Press, stands as a leading platform in the field of cardiovascular and thoracic research. With an E-ISSN of 2753-670X, this journal aims to bridge the gap between various disciplines, encompassing advancements in surgical techniques, clinical practices, and innovative therapeutic approaches. It encourages contributions from researchers and practitioners alike, promoting collaboration and academic discourse among diverse specialties. With its commitment to open-access publishing, the journal ensures that cutting-edge research is readily available to a global audience, fostering knowledge sharing and enhancing patient care within the cardiovascular and thoracic communities. As the journal continues to evolve, it solidifies its importance as an essential resource for those dedicated to advancing the field.

Translational Lung Cancer Research is a leading journal dedicated to advancing the field of oncology, particularly focusing on groundbreaking discoveries in lung cancer treatment and management. Published by AME Publishing Company, this journal boasts an impressive Q1 classification in the 2023 Oncology category, reflecting its significant contribution to the scientific community, with an outstanding Scopus rank of #92 out of 404 in Medicine _ Oncology, placing it in the 77th percentile. With its commitment to open access, the journal fosters international collaboration and accessibility, making cutting-edge research available to a wide audience. The scope of Translational Lung Cancer Research encompasses clinical trials, experimental studies, and translational research that bridge the gap between laboratory findings and clinical applications. Researchers, professionals, and students seeking to keep abreast of the latest developments in lung cancer research will find invaluable insights within its pages. For further information, please contact at FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG.

Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.